Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
DEHYDRATED ALCOHOL vs ACETIC ACID
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Dehydrated alcohol (ethanol) causes tissue necrosis by protein denaturation and cellular dehydration, leading to vascular thrombosis and ischemic infarction. It ablates nerve tissue by extracting lipids and precipitating proteins.
Acetic acid exerts antimicrobial effects by disrupting bacterial cell membranes and lowering local p H, creating an unfavorable environment for pathogen growth. It also acts as a keratolytic agent by dissolving intercellular cement substance and causing desquamation.
FDA-approved for adjunctive therapy in the treatment of cystic thyroid nodules,Off-label: Neurolysis for celiac plexus block in pancreatic cancer pain,Off-label: Ablation of hepatocellular carcinoma,Off-label: Sclerotherapy for esophageal varices
FDA-approved as an otic solution for the treatment of superficial bacterial infections of the external auditory canal (otitis externa),Off-label: treatment of vaginal infections, wound irrigation, removal of granulation tissue, and as a topical agent for certain dermatophyte infections
Intravenous administration: 0.1-1 m L of sterile dehydrated alcohol (100% ethanol) injected directly into cystic lesions or tumors under imaging guidance. Maximum volume per injection: 1 m L, repeated up to 3 times per session depending on lesion size.
For irrigation: 0.25% to 5% solution as needed during surgery. For otitis externa: 2% otic solution, 3-4 drops in affected ear every 2-3 hours for 7 days.
2-4 hours in most individuals at zero-order kinetics; terminal half-life is concentration-dependent due to saturation of alcohol dehydrogenase. Clinically, elimination rate is constant at 15-20 mg/d L/hour in non-tolerant individuals.
Terminal half-life approximately 9-10 minutes (in plasma) due to rapid metabolism; clinical context: negligible accumulation.
Primarily hepatic via alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH); minor metabolism via CYP2E1 at high concentrations.
Acetic acid is primarily metabolized via the tricarboxylic acid (TCA) cycle after conversion to acetyl-Co A; no specific cytochrome P450 enzymes involved.
Ethanol is primarily eliminated by hepatic metabolism (90-98%) via alcohol dehydrogenase and aldehyde dehydrogenase, with 2-10% excreted unchanged in urine, breath, and sweat. Renal elimination is minor and variable.
Primarily renal; acetic acid is rapidly metabolized via the tricarboxylic acid cycle to carbon dioxide and water, with less than 1% excreted unchanged in urine. Biliary/fecal excretion negligible.
Negligible (<5%); no specific binding proteins.
Negligible (<10%); not bound to plasma proteins.
0.5-0.7 L/kg, approximating total body water. Higher in females due to lower lean body mass.
Approximately 0.5 L/kg; distributes into total body water.
Oral: ~80-100% due to rapid absorption from stomach and small intestine; IV: 100%.
Oral: essentially complete (rapidly absorbed and metabolized); topical: local effect only, systemic absorption minimal.
No dosage adjustment required for renal impairment.
No specific dose adjustment required for topical or irrigation use. For systemic absorption, caution in severe renal impairment; no formal guidelines.
No specific Child-Pugh-based adjustments; use with caution in severe hepatic dysfunction due to potential accumulation.
No dose adjustment necessary for topical or irrigation use; hepatic impairment unlikely to affect safety.
Not recommended for use in pediatric patients due to lack of safety and efficacy data.
For otitis externa: 2% otic solution, 3-4 drops in affected ear every 2-3 hours; for irrigation: 0.25% solution as needed, weight-based not specified.
No specific dose adjustment; use with caution due to age-related comorbidities and potential for increased sensitivity.
No specific adjustment; use standard dosing with caution for skin integrity and hearing in elderly.
No FDA boxed warning exists for dehydrated alcohol. However, it should only be administered by physicians experienced in injection techniques for specific indications due to risk of tissue necrosis and nerve damage.
None
Risk of tissue necrosis and sloughing if extravasation occurs,Neurological injury if injected near nerves (e.g., peripheral nerve damage, paralysis),Hypotension and bradycardia during celiac plexus block,Alcohol intoxication and CNS depression if absorbed systemically,Use with caution in patients with liver disease or diabetes mellitus
For external use only; avoid contact with eyes and mucous membranes. Prolonged use may cause overgrowth of nonsusceptible organisms. Discontinue if irritation or sensitization occurs. Use with caution in patients with perforated tympanic membrane (otic use) due to risk of ototoxicity.
Hypersensitivity to ethanol or any component of the formulation,Acute infection at the injection site,Uncorrectable coagulation abnormalities,Pregnancy (relative contraindication due to fetal alcohol spectrum disorders)
Hypersensitivity to acetic acid or any component of the formulation. Perforated tympanic membrane (for otic preparations).
No specific food interactions. However, avoid alcohol consumption for 24 hours post-procedure due to risk of additive CNS depression.
No specific food interactions with topical or irrigation use. If ingested accidentally, avoid further oral intake and seek medical attention immediately.
First trimester: Data limited; alcohol is a known teratogen causing fetal alcohol spectrum disorders. Increased risk of congenital anomalies (e.g., heart defects, microcephaly) with high systemic exposure. Second trimester: Continued risk for growth restriction and neurodevelopmental abnormalities. Third trimester: Risk of growth retardation, preterm birth, and neurobehavioral deficits. Avoid systemic use; local injection for nerve block or ablation has minimal systemic absorption but caution advised.
Acetic acid is not associated with teratogenicity at concentrations used clinically. No trimester-specific risks have been identified.
Alcohol is excreted into breast milk; M/P ratio approximately 1.0. Chronic ingestion can impair infant motor development. Dehydrated alcohol for therapeutic injection likely results in negligible systemic levels; however, avoid breastfeeding immediately after procedure. Advise discarding milk for 2-3 hours post-procedure.
Acetic acid is a normal constituent of breast milk. Exogenous administration is unlikely to pose risk due to rapid metabolism. M/P ratio not established.
No dose adjustment needed for localized injection; pharmacokinetics of ethanol unchanged in pregnancy. Avoid use as systemic agent; use alternative if possible.
No dose adjustment is necessary during pregnancy as pharmacokinetics are not significantly altered.
Absolute ethanol (dehydrated alcohol) is used for neurolysis in celiac plexus block for pancreatic cancer pain and for ablation of certain soft tissue lesions. Administer slowly to avoid local toxicity. Inadvertent intravascular injection can cause immediate pain and tissue necrosis. Use ultrasound or CT guidance for accurate placement. Monitor for hypotension, pain, and transient alcohol intoxication. Contraindicated in patients with bleeding disorders or local infection.
Acetic acid (0.25-2%) is used for irrigation of the bladder or urinary catheter to prevent or treat infection by urease-producing organisms (e.g., Proteus). It acidifies urine, inhibiting bacterial growth and preventing struvite stone formation. Use sterile solutions only; dilute concentrated acetic acid before use. Not for systemic absorption. Monitor urine p H (target <5.5).
You may feel a temporary burning sensation at the injection site.,This medication is used to block pain signals from certain nerves.,Avoid alcohol consumption for 24 hours after the procedure to prevent additive effects.,Report any severe pain, bleeding, or signs of infection to your healthcare provider.,You may experience temporary dizziness or lightheadedness after the injection.
Use only as directed by your healthcare provider.,Do not ingest or apply to broken skin.,Report any burning, pain, or irritation during use.,Keep out of reach of children.,Store at room temperature away from moisture.
No interactions on record
"Phenylacetic acid, a metabolite of phenylalanine, may reduce the cardiotoxic effects of digitoxin by interfering with Na+/K+-ATPase binding or enhancing digitoxin clearance. This interaction could theoretically decrease the efficacy of digitoxin in treating heart failure or arrhythmias, though the clinical relevance is unclear. Monitoring for reduced digitoxin effect and adjusting doses may be necessary."
"Topical alclometasone, a corticosteroid, may potentially induce systemic metabolic changes that could theoretically reduce the efficacy of phenylacetic acid, a compound used in metabolic therapies. By enhancing gluconeogenesis and altering hepatic enzyme activity, corticosteroids can counteract the metabolic effects of phenylacetic acid, potentially diminishing its therapeutic benefit in conditions like hyperammonemia. Clinical observation of reduced ammonia-lowering effect or worsened metabolic control may occur if these agents are used together."
"Estrone, an estrogen hormone, may induce hepatic enzymes involved in the metabolism of phenylacetic acid, thereby increasing its clearance. This pharmacokinetic interaction could lead to reduced plasma concentrations of phenylacetic acid, potentially diminishing its therapeutic efficacy in conditions such as hyperammonemia or as an anti-neoplastic adjunct. Clinically, patients may experience suboptimal response to phenylacetic acid therapy when co-administered with estrone."
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about DEHYDRATED ALCOHOL vs ACETIC ACID, answered by our medical review team.
DEHYDRATED ALCOHOL is a Sclerosing agent that works by Dehydrated alcohol (ethanol) causes tissue necrosis by protein denaturation and cellular dehydration, leading to vascular thrombosis and ischemic infarction. It ablates nerve tissue by extracting lipids and precipitating proteins.. ACETIC ACID is a Topical Antiseptic that works by Acetic acid exerts antimicrobial effects by disrupting bacterial cell membranes and lowering local p H, creating an unfavorable environment for pathogen growth. It also acts as a keratolytic agent by dissolving intercellular cement substance and causing desquamation.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between DEHYDRATED ALCOHOL and ACETIC ACID depend on the specific clinical indication. These are agents from distinct pharmacological classes and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of DEHYDRATED ALCOHOL is: Intravenous administration: 0.1-1 m L of sterile dehydrated alcohol (100% ethanol) injected directly into cystic lesions or tumors under imaging guidance. Maximum volume per injection: 1 m L, repeated up to 3 times per session depending on lesion size.. The standard adult dose of ACETIC ACID is: For irrigation: 0.25% to 5% solution as needed during surgery. For otitis externa: 2% otic solution, 3-4 drops in affected ear every 2-3 hours for 7 days.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between DEHYDRATED ALCOHOL and ACETIC ACID in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. DEHYDRATED ALCOHOL is classified as Category C. First trimester: Data limited; alcohol is a known teratogen causing fetal alcohol spectrum disorders. Increased risk of congenital anomalies (e.g., heart defects, microcephaly) wit. ACETIC ACID is classified as Category C. Acetic acid is not associated with teratogenicity at concentrations used clinically. No trimester-specific risks have been identified.. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.